Gene Therapy CDMO Forges Ahead with $120M Series B Financing
Four Biotechs Rake in Over $350 Million for Rare Diseases, Cancers and More
Gene therapy company secures largest series B financing in Ohio’s history
Drive-backed gene therapy startup raises $120M to amp up biotech manufacturing in Grove City
Gene therapy ‘development engine’ scores $120M to beef up contract manufacturing
Forge Biologics bags $120M round as it looks to scale AAV manufacturing for Krabbe disease treatment
Trial OKed for Rare Disease Gene Therapy
